Idarubicin (HCl)

Overview

Categories

Primary Characterstics

Indications

Back to top

Pharmacokinetics

Back to top

Contraindications

Back to top

Drug Interactions

Back to top

Side Effects

Back to top

Dosage

Idarubicin (HCl)'s dosage details are as follows:
Dose Single Dose Frequency Route Instructions

Adult Dosage

30 mg/m230 (30)24 hourlyDaily for 3 day for leukemia.
45 mg/m245 (45)24 hourlyFor reftractory breast cancer.
12 mg/m sq.22 (22)24 hourlySlow IVOver 10-15 minutes.

Paedriatic Dosage (20kg)

45 mg/m245 (45)As recommended.For 3 days.

Neonatal Dosage (3kg)

No data regarding the neonatal dosage details of Idarubicin (HCl) is available.

High Risk Groups

Back to top

Warning / Precautions

Back to top

Storage Conditions

Back to top

Interference in Pathology

Back to top

Brands / Trade Names of Idarubicin (HCl)

Back to top

Manufacturers of Idarubicin (HCl) in Pakistan

Al-Habib Pfizer

Back to top

Previous Drug Generic - Next Drug Generic